CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,833,628 | +62.4% | 308,007 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $7,284,727 | +58.9% | 314,675 | +79.8% | 0.00% | 0.0% |
| Q4 2022 | $4,585,603 | +67.7% | 175,023 | +25.8% | 0.00% | – |
| Q3 2022 | $2,735,000 | +85.4% | 139,113 | +65.0% | 0.00% | – |
| Q2 2022 | $1,475,000 | +36.3% | 84,294 | +27.5% | 0.00% | – |
| Q1 2022 | $1,082,000 | -69.5% | 66,123 | -69.6% | 0.00% | – |
| Q4 2021 | $3,552,000 | +28.6% | 217,785 | +0.6% | 0.00% | – |
| Q3 2021 | $2,761,000 | -9.7% | 216,412 | -0.0% | 0.00% | – |
| Q2 2021 | $3,057,000 | +19.8% | 216,470 | +31.8% | 0.00% | – |
| Q1 2021 | $2,552,000 | +1.8% | 164,211 | +3.9% | 0.00% | – |
| Q4 2020 | $2,508,000 | – | 158,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |